Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis
Urologic Oncology: Seminars and Original Investigations Nov 21, 2017
Grenga I, et al. - The effect of M7824 on invasive urothelial carcinoma cell lines was evaluated in this research. The immunomodulatory properties of M7824 on both tumor cell phenotype and immune-mediated lysis were illustrated. M7824 induced immunogenic modulation of urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis compared to anti-PD-L1 or M7824mut. Hence, the relevance of the dual blockade of PD-L1 and TGFβ in urothelial carcinoma cell lines and thus support the rationale were displayed for prospective trials of M7824 in patients with urothelial cancer.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries